Lamivudine Tablet, Film Coated
Product Images NDC 60505-3252

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 60505-3252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl150mg60s.jpg (Lbl150mg60s)

Each film-coated tablet contains 150 mg lamivudine. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and can be tolerated at temperatures between 15°C to 30°C (59°F to 86°F). The drug should be protected from moisture. The usual dosage should be checked from the package insert. The package includes 60 tablets of Lamivudine, USP with National Drug Code 60505-3251-6 by APOTEX CORP. The origin or manufacturing site seems to be Fion, Firica 22226.*

FDA Label Image

Lbl300mg30s.jpg (Lbl300mg30s)

Each film-coated tablet contains 300mg lamivudine. They should be stored at a temperature between 20°C and 25°C and can be kept between 15°C and 30°C for a short duration. The medication should be protected from moisture. The usual dosage for the medication can be found in the package insert. The tablets are manufactured by Apotex Corp. The rest of the information is not available.*

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure1 (Figure1)

Lamivudine is a medication available in two dosages of 150mg taken twice a day or 300mg taken once a day. The provided text also includes a graph displaying the treatment time in weeks with corresponding numerical values on the x-axis.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.